KATHRYN JOHNSON: Open Payments
NPI 1972164291 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$31,155 in 60 payments from 7 companies in 2025. Trend: 2023 $6,157 · 2024 $9,764 · 2025 $31,155
Speaker / faculty: $16,599Travel & lodging: $7,950Consulting: $4,910Food & beverage: $1,697
| Company | Payments | Amount |
|---|---|---|
| SOBI, INC | 42 | $27,862 |
| GlaxoSmithKline, LLC. | 10 | $3,092 |
| Novartis Pharmaceuticals Corporation | 3 | $64 |
| Blueprint Medicines Corporation | 2 | $62 |
| Daiichi Sankyo Inc. | 1 | $29 |
| Rigel Pharmaceuticals, Inc. | 1 | $23 |
| Kite Pharma, Inc. | 1 | $23 |
Products named: Vonjo, OJJAARA, SCEMBLIX, AYVAKIT, Vanflyta, TAVALISSE, Yescarta.
Industry payments across NY — which companies pay providers there.
